Literature DB >> 32512823

Implications of Hereditary Origin on the Immune Phenotype of Mismatch Repair-Deficient Cancers: Systematic Literature Review.

Lena Bohaumilitzky1,2,3, Magnus von Knebel Doeberitz1,2,3, Matthias Kloor1,2,3, Aysel Ahadova1,2,3.   

Abstract

Microsatellite instability (MSI) represents one of the major types of genomic instability in human cancers and is most common in colorectal cancer (CRC) and endometrial cancer (EC). MSI develops as a consequence of DNA mismatch repair (MMR) deficiency, which can occur sporadically or in the context of Lynch syndrome (LS), the most common inherited tumor syndrome. MMR deficiency triggers the accumulation of high numbers of somatic mutations in the affected cells, mostly indel mutations at microsatellite sequences. MSI tumors are among the most immunogenic human tumors and are often characterized by pronounced local immune responses. However, so far, little is known about immunological differences between sporadic and hereditary MSI tumors. Therefore, a systematic literature search was conducted to comprehensively collect data on the differences in local T cell infiltration and immune evasion mechanisms between sporadic and LS-associated MSI tumors. The vast majority of collected studies were focusing on CRC and EC. Generally, more pronounced T cell infiltration and a higher frequency of B2M mutations were reported for LS-associated compared to sporadic MSI tumors. In addition, phenotypic features associated with enhanced lymphocyte recruitment were reported to be specifically associated with hereditary MSI CRCs. The quantitative and qualitative differences clearly indicate a distinct biology of sporadic and hereditary MSI tumors. Clinically, these findings underline the need for differentiating sporadic and hereditary tumors in basic science studies and clinical trials, including trials evaluating immune checkpoint blockade therapy in MSI tumors.

Entities:  

Keywords:  DNA mismatch repair deficiency; Lynch syndrome; colorectal cancer; immune evasion; immune infiltration; microsatellite instability

Year:  2020        PMID: 32512823     DOI: 10.3390/jcm9061741

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  6 in total

Review 1.  Vaccines for immunoprevention of DNA mismatch repair deficient cancers.

Authors:  Alejandro Hernandez-Sanchez; Mark Grossman; Kevin Yeung; Shizuko S Sei; Steven Lipkin; Matthias Kloor
Journal:  J Immunother Cancer       Date:  2022-06       Impact factor: 12.469

Review 2.  An Update on Immune Checkpoint Therapy for the Treatment of Lynch Syndrome.

Authors:  Christina Therkildsen; Lars Henrik Jensen; Maria Rasmussen; Inge Bernstein
Journal:  Clin Exp Gastroenterol       Date:  2021-05-24

Review 3.  Challenges of Neoantigen Targeting in Lynch Syndrome and Constitutional Mismatch Repair Deficiency Syndrome.

Authors:  Asima Abidi; Mark A J Gorris; Evan Brennan; Marjolijn C J Jongmans; Dilys D Weijers; Roland P Kuiper; Richarda M de Voer; Nicoline Hoogerbrugge; Gerty Schreibelt; I Jolanda M de Vries
Journal:  Cancers (Basel)       Date:  2021-05-13       Impact factor: 6.639

Review 4.  Relationship between microsatellite status and immune microenvironment of colorectal cancer and its application to diagnosis and treatment.

Authors:  Junge Bai; Hongsheng Chen; Xuefeng Bai
Journal:  J Clin Lab Anal       Date:  2021-05-03       Impact factor: 2.352

5.  Endometrial cancer: a genetic point of view.

Authors:  Bianca Bianco; Caio Parente Barbosa; Camila Martins Trevisan; Antonio Simone Laganà; Erik Montagna
Journal:  Transl Cancer Res       Date:  2020-12       Impact factor: 1.241

Review 6.  The therapeutic and prognostic implications of immunobiology in colorectal cancer: a review.

Authors:  Alexandra M Zaborowski; Des C Winter; Lydia Lynch
Journal:  Br J Cancer       Date:  2021-07-23       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.